Solving Clinical Challenges in Child and Adolescent Psychiatry
Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN
Solving Clinical Challenges addresses complex conundrums that are faced by Psych Congress attendees in managing children and adolescents. Dr. Carbray will discuss and respond to real cases and real issues from attendees who were surveyed prior to the conference. Challenges that may be covered include: 1) diagnostic nosology, accurate diagnosis, and screening; 2) pharmacologic treatments; 3) side effect management; and 4) nonpharmacologic treatments.
Stimulants in ADHD: Friend or Foe?
Timothy E. Wilens, MD
Stimulant medications are among first-line agents for attention-deficit/hyperactivity disorder (ADHD) across the lifespan. While highly efficacious, the stimulants also have short- and long-term potential adverse effects. Additionally, stimulants are now the most common nonmedically used prescription medications in young people. This session will highlight shorter- and longer-term effectiveness data with the stimulants in young people with ADHD; describe the context and characteristics of the nonmedical use of prescription stimulant medications; and review guidelines around the safe administration and monitoring of stimulants in high-risk groups with ADHD.
Bipolar Disorders in Children and Adolescents: Recognition and Treatment Update
Kiki D. Chang, MD
Bipolar disorders (BD) occur in 1% to 2% of the youth population and carry high morbidity and mortality—even higher than adult-onset bipolar disorder. This session will provide up-to-date knowledge regarding the incidence and recognition of BD in youth. The latest treatment options, including psychotherapy and medications, will be reviewed. Finally, identification and prevention of BD in youth at high-risk will be considered.